<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01284764</url>
  </required_header>
  <id_info>
    <org_study_id>HGI-2011-01</org_study_id>
    <nct_id>NCT01284764</nct_id>
  </id_info>
  <brief_title>Efficacy Study of a Low Volume of Water Intake and Mosapride for Endoscopy in Patients With Subtotal Gastrectomy</brief_title>
  <acronym>SMW</acronym>
  <official_title>Efficacy of a Low Volume of Water Intake and Mosapride for Endoscopy Preparation in Gastric Cancer Patients With Subtotal Gastrectomy: A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Inje University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Inje University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A low volume of water intake and mosapride will effectively reduce food residue in remnant
      stomach for patients who had undergone subtotal gastrectomy due to gastric cancer.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      We evaluate that a 500mL of water intake and mosapride will effectively reduce food residue
      in remnant stomach for patients who had undergone subtotal gastrectomy due to gastric cancer.
      We plan to compare this method with routine midnight fasting method for endoscopy in patients
      with subtotal gastrectomy.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2011</start_date>
  <completion_date type="Actual">September 2011</completion_date>
  <primary_completion_date type="Actual">July 2011</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Degrees of food residue using endoscopic scoring system</measure>
    <time_frame>six months</time_frame>
    <description>We plan to evaluate how much a low volume of water and mosapride, compared with routine fasting, reduse food residue in gastric remnant for endoscopy.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Tolerability of a low volume of water and mosapride</measure>
    <time_frame>six months</time_frame>
    <description>We plan to evaluate tolerability of a low volume of water and mosapride compared with routine fasting for endoscopy preparation in patients with subtotal gastrectomy</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">144</enrollment>
  <condition>Foreign Body Left During Endoscopic Examination</condition>
  <arm_group>
    <arm_group_label>midnight fasting</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>The patients in this group will have midnight fasting the day before endoscopic examination</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Mosapride, low volume of water</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The patients in this group will take mosapride and a 500mL water at evening of the day before endoscopic examination.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Mosapride</intervention_name>
    <description>Mosapride 10mg, one dosage, once evening of the day before the endoscopy</description>
    <arm_group_label>Mosapride, low volume of water</arm_group_label>
    <other_name>Gasmotin</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Outpatients who had subtotal gastrectomy for gastric cancer

        Exclusion Criteria:

          -  Pregnancy

          -  Lactation

          -  History of anastomotic stricture

          -  Recurrent advanced gastric cancer

          -  Poor general condition( &gt; 2 ECOG)

          -  Other disseminated malignancy

          -  Significant renal failure or congestive heart failure (CHF)

          -  Liver failure
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eun Hee Seo, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Haeundae Paik Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Tae Oh Kim, Ph.D.</last_name>
    <role>Study Director</role>
    <affiliation>Haeundae Paik Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Haeundae Paik Hospital, Inje University School of Medicine</name>
      <address>
        <city>Busan</city>
        <zip>612-030</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>October 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 26, 2011</study_first_submitted>
  <study_first_submitted_qc>January 26, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 27, 2011</study_first_posted>
  <last_update_submitted>October 4, 2011</last_update_submitted>
  <last_update_submitted_qc>October 4, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 5, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Inje University</investigator_affiliation>
    <investigator_full_name>Eun Hee Seo</investigator_full_name>
    <investigator_title>fellow</investigator_title>
  </responsible_party>
  <keyword>Endoscopy</keyword>
  <keyword>Gastrectomy</keyword>
  <keyword>Stomach neoplasms</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Foreign Bodies</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mosapride</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

